IL33 and Myocardial fibrosis: IL-33 is a cytokine produced by cardiac fibroblasts that can cause cardioprotective effects against hypertrophic remodeling and myocardial fibrosis by antagonizing angiotensin-II signaling and promoting anti-apoptotic factors, respectively [77, 78].